1	Autotaxin	_	NN	_	_	11	VMOD	_	_
2	(	_	(	_	_	3	P	_	_
3	ATX	_	NN	_	_	1	PRN	_	_
4	)	_	)	_	_	3	P	_	_
5	,	_	,	_	_	1	P	_	_
6	a	_	DT	_	_	9	NMOD	_	_
7	potent	_	JJ	_	_	9	NMOD	_	_
8	tumor	_	NN	_	_	9	NMOD	_	_
9	motogen	_	NN	_	_	1	APPO	_	_
10	,	_	,	_	_	1	P	_	_
11	augments	_	VBZ	_	_	0	ROOT	_	_
12	invasive	_	JJ	_	_	15	NMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	metastatic	_	JJ	_	_	13	CONJ	_	_
15	potential	_	NN	_	_	11	VMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	ras-transformed	_	JJ	_	_	18	NMOD	_	_
18	cells	_	NNS	_	_	16	PMOD	_	_
19	.	_	.	_	_	11	P	_	_
		
1	Autotaxin	_	NN	_	_	12	VMOD	_	_
2	(	_	(	_	_	3	P	_	_
3	ATX	_	NN	_	_	1	PRN	_	_
4	)	_	)	_	_	3	P	_	_
5	,	_	,	_	_	1	P	_	_
6	an	_	DT	_	_	8	NMOD	_	_
7	exo-nucleotide	_	JJ	_	_	8	NMOD	_	_
8	pyrophosphatase	_	NN	_	_	1	APPO	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	phosphodiesterase	_	NN	_	_	9	CONJ	_	_
11	,	_	,	_	_	1	P	_	_
12	was	_	VBD	_	_	0	ROOT	_	_
13	originally	_	RB	_	_	12	VMOD	_	_
14	isolated	_	VBN	_	_	12	VC	_	_
15	as	_	IN	_	_	14	VMOD	_	_
16	a	_	DT	_	_	18	NMOD	_	_
17	potent	_	JJ	_	_	18	NMOD	_	_
18	stimulator	_	NN	_	_	15	PMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	tumor	_	NN	_	_	22	NMOD	_	_
21	cell	_	NN	_	_	22	NMOD	_	_
22	motility	_	NN	_	_	19	PMOD	_	_
23	.	_	.	_	_	12	P	_	_
		
1	In	_	IN	_	_	19	VMOD	_	_
2	order	_	NN	_	_	1	DEP	_	_
3	to	_	TO	_	_	1	SUB	_	_
4	study	_	VB	_	_	3	IM	_	_
5	whether	_	IN	_	_	4	VMOD	_	_
6	ATX	_	NN	_	_	7	NMOD	_	_
7	expression	_	NN	_	_	8	VMOD	_	_
8	affects	_	VBZ	_	_	5	SUB	_	_
9	motility-dependent	_	JJ	_	_	10	NMOD	_	_
10	processes	_	NNS	_	_	8	VMOD	_	_
11	such	_	JJ	_	_	12	DEP	_	_
12	as	_	IN	_	_	10	NMOD	_	_
13	invasion	_	NN	_	_	12	PMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	metastasis	_	NN	_	_	14	CONJ	_	_
16	,	_	,	_	_	19	P	_	_
17	we	_	PRP	_	_	19	VMOD	_	_
18	stably	_	RB	_	_	19	VMOD	_	_
19	transfected	_	VBD	_	_	0	ROOT	_	_
20	full-length	_	JJ	_	_	22	NMOD	_	_
21	ATX	_	NN	_	_	22	NMOD	_	_
22	cDNA	_	NN	_	_	19	VMOD	_	_
23	into	_	IN	_	_	19	VMOD	_	_
24	two	_	CD	_	_	27	NMOD	_	_
25	non-expressing	_	JJ	_	_	27	NMOD	_	_
26	cell	_	NN	_	_	27	NMOD	_	_
27	lines	_	NNS	_	_	23	PMOD	_	_
28	,	_	,	_	_	27	P	_	_
29	parental	_	JJ	_	_	27	COORD	_	_
30	and	_	CC	_	_	29	COORD	_	_
31	ras-transformed	_	JJ	_	_	36	NMOD	_	_
32	NIH3T3	_	NN	_	_	36	NMOD	_	_
33	(	_	(	_	_	36	P	_	_
34	clone7	_	NN	_	_	36	NMOD	_	_
35	)	_	)	_	_	36	P	_	_
36	cells	_	NNS	_	_	30	CONJ	_	_
37	.	_	.	_	_	19	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	effect	_	NN	_	_	11	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	ATX	_	NN	_	_	5	NMOD	_	_
5	secretion	_	NN	_	_	3	PMOD	_	_
6	on	_	IN	_	_	2	NMOD	_	_
7	in	_	FW	_	_	8	AMOD	_	_
8	vitro	_	FW	_	_	10	NMOD	_	_
9	cell	_	NN	_	_	10	NMOD	_	_
10	motility	_	NN	_	_	6	PMOD	_	_
11	was	_	VBD	_	_	0	ROOT	_	_
12	variable	_	JJ	_	_	11	VMOD	_	_
13	.	_	.	_	_	11	P	_	_
		
1	The	_	DT	_	_	5	NMOD	_	_
2	ras-transformed	_	JJ	_	_	5	NMOD	_	_
3	,	_	,	_	_	2	P	_	_
4	ATX-secreting	_	JJ	_	_	2	COORD	_	_
5	subclones	_	NNS	_	_	6	VMOD	_	_
6	had	_	VBD	_	_	0	ROOT	_	_
7	enhanced	_	VBN	_	_	8	NMOD	_	_
8	motility	_	NN	_	_	6	VMOD	_	_
9	to	_	TO	_	_	8	NMOD	_	_
10	ATX	_	NN	_	_	9	PMOD	_	_
11	as	_	IN	_	_	6	VMOD	_	_
12	chemoattractant	_	NN	_	_	11	PMOD	_	_
13	,	_	,	_	_	6	P	_	_
14	but	_	CC	_	_	6	COORD	_	_
15	there	_	EX	_	_	16	VMOD	_	_
16	was	_	VBD	_	_	14	CONJ	_	_
17	little	_	JJ	_	_	18	NMOD	_	_
18	difference	_	NN	_	_	16	VMOD	_	_
19	in	_	IN	_	_	16	VMOD	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	motility	_	NN	_	_	22	NMOD	_	_
22	responses	_	NNS	_	_	19	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	NIH3T3	_	NN	_	_	25	NMOD	_	_
25	cells	_	NNS	_	_	23	PMOD	_	_
26	transfected	_	VBN	_	_	25	APPO	_	_
27	with	_	IN	_	_	26	VMOD	_	_
28	atx	_	NN	_	_	27	PMOD	_	_
29	,	_	,	_	_	28	P	_	_
30	an	_	DT	_	_	32	NMOD	_	_
31	inactive	_	JJ	_	_	32	NMOD	_	_
32	mutant	_	NN	_	_	33	NMOD	_	_
33	gene	_	NN	_	_	28	COORD	_	_
34	,	_	,	_	_	33	P	_	_
35	or	_	CC	_	_	33	COORD	_	_
36	empty	_	JJ	_	_	37	NMOD	_	_
37	vector	_	NN	_	_	35	CONJ	_	_
38	.	_	.	_	_	6	P	_	_
		
1	In	_	IN	_	_	15	VMOD	_	_
2	MatrigelTM	_	NN	_	_	4	NMOD	_	_
3	invasion	_	NN	_	_	4	NMOD	_	_
4	assays	_	NNS	_	_	1	PMOD	_	_
5	,	_	,	_	_	15	P	_	_
6	all	_	DT	_	_	7	NMOD	_	_
7	subclones	_	NNS	_	_	15	VMOD	_	_
8	,	_	,	_	_	7	P	_	_
9	which	_	WDT	_	_	10	VMOD	_	_
10	secreted	_	VBN	_	_	7	NMOD	_	_
11	enzymatically	_	RB	_	_	12	AMOD	_	_
12	active	_	JJ	_	_	13	NMOD	_	_
13	ATX	_	NN	_	_	10	VMOD	_	_
14	,	_	,	_	_	7	P	_	_
15	demonstrated	_	VBD	_	_	0	ROOT	_	_
16	greater	_	JJR	_	_	17	AMOD	_	_
17	spontaneous	_	JJ	_	_	20	NMOD	_	_
18	and	_	CC	_	_	17	COORD	_	_
19	ATX-stimulated	_	JJ	_	_	18	CONJ	_	_
20	invasion	_	NN	_	_	15	VMOD	_	_
21	than	_	IN	_	_	15	VMOD	_	_
22	appropriate	_	JJ	_	_	23	NMOD	_	_
23	controls	_	NNS	_	_	21	PMOD	_	_
24	.	_	.	_	_	15	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	difference	_	NN	_	_	5	VMOD	_	_
3	in	_	IN	_	_	2	NMOD	_	_
4	invasiveness	_	NNS	_	_	3	PMOD	_	_
5	was	_	VBD	_	_	0	ROOT	_	_
6	not	_	RB	_	_	5	VMOD	_	_
7	caused	_	VBN	_	_	5	VC	_	_
8	by	_	IN	_	_	7	VMOD	_	_
9	differences	_	NNS	_	_	8	PMOD	_	_
10	in	_	IN	_	_	9	NMOD	_	_
11	gelatinase	_	NN	_	_	12	NMOD	_	_
12	production	_	NN	_	_	10	PMOD	_	_
13	,	_	,	_	_	12	P	_	_
14	which	_	WDT	_	_	15	VMOD	_	_
15	was	_	VBD	_	_	12	NMOD	_	_
16	constant	_	JJ	_	_	15	VMOD	_	_
17	within	_	IN	_	_	15	VMOD	_	_
18	each	_	DT	_	_	19	NMOD	_	_
19	group	_	NN	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	transfectants	_	NNS	_	_	20	PMOD	_	_
22	.	_	.	_	_	5	P	_	_
		
1	In	_	FW	_	_	2	AMOD	_	_
2	vivo	_	FW	_	_	3	NMOD	_	_
3	studies	_	NNS	_	_	8	VMOD	_	_
4	with	_	IN	_	_	3	NMOD	_	_
5	athymic	_	JJ	_	_	7	NMOD	_	_
6	nude	_	JJ	_	_	7	NMOD	_	_
7	mice	_	NNS	_	_	4	PMOD	_	_
8	demonstrated	_	VBD	_	_	0	ROOT	_	_
9	that	_	IN	_	_	8	VMOD	_	_
10	injection	_	NN	_	_	15	VMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	atx-transfected	_	JJ	_	_	14	NMOD	_	_
13	NIH3T3	_	NN	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	11	PMOD	_	_
15	resulted	_	VBD	_	_	9	SUB	_	_
16	in	_	IN	_	_	15	VMOD	_	_
17	a	_	DT	_	_	20	NMOD	_	_
18	weak	_	JJ	_	_	20	NMOD	_	_
19	tumorigenic	_	JJ	_	_	20	NMOD	_	_
20	capacity	_	NN	_	_	16	PMOD	_	_
21	with	_	IN	_	_	20	NMOD	_	_
22	few	_	JJ	_	_	24	NMOD	_	_
23	experimental	_	JJ	_	_	24	NMOD	_	_
24	metastases	_	NNS	_	_	21	PMOD	_	_
25	.	_	.	_	_	8	P	_	_
		
1	Combination	_	NN	_	_	8	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	ATX	_	NN	_	_	4	NMOD	_	_
4	expression	_	NN	_	_	2	PMOD	_	_
5	with	_	IN	_	_	1	NMOD	_	_
6	ras	_	NN	_	_	7	NMOD	_	_
7	transformation	_	NN	_	_	5	PMOD	_	_
8	produced	_	VBD	_	_	0	ROOT	_	_
9	cells	_	NNS	_	_	8	VMOD	_	_
10	with	_	IN	_	_	8	VMOD	_	_
11	greatly	_	RB	_	_	12	AMOD	_	_
12	amplified	_	VBN	_	_	13	NMOD	_	_
13	tumorigenesis	_	NN	_	_	10	PMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	metastatic	_	JJ	_	_	16	NMOD	_	_
16	potential	_	NN	_	_	14	CONJ	_	_
17	compared	_	VBN	_	_	8	VMOD	_	_
18	to	_	TO	_	_	17	PMOD	_	_
19	ras-transformed	_	JJ	_	_	20	NMOD	_	_
20	controls	_	NNS	_	_	18	PMOD	_	_
21	.	_	.	_	_	8	P	_	_
		
1	Thus	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	ATX	_	NN	_	_	4	VMOD	_	_
4	appears	_	VBZ	_	_	0	ROOT	_	_
5	to	_	TO	_	_	4	VMOD	_	_
6	augment	_	VB	_	_	5	IM	_	_
7	cellular	_	JJ	_	_	8	NMOD	_	_
8	characteristics	_	NNS	_	_	6	VMOD	_	_
9	necessary	_	JJ	_	_	8	APPO	_	_
10	for	_	IN	_	_	9	AMOD	_	_
11	tumor	_	NN	_	_	12	NMOD	_	_
12	aggressiveness	_	NN	_	_	10	PMOD	_	_
13	.	_	.	_	_	4	P	_	_
		
